ATRX and neoplasm: In the present study, we demonstrated that Atrx mutation facilitated T cell infiltration into the LLC tumor microenvironment, elevated PD-L1 and pMHC I expression on LLC cell surfaces, and enhanced T cell cytotoxicity in vitro, which is in accordance with previous reports in other SWI/SNF genes.